The federal government will stop being the predominant purchaser of Covid-19 vaccines, treatments, and tests at some point this fall. White House Covid-19 Response Team coordinator Dr Ashish Jha said his “hope is that in 2023 you're going to see commercialization of almost all of these products.”
Subscribe to:
Post Comments (Atom)
< + > ŌURA Secures $200 Million in Series D Funding
Investments from Fidelity Management & Research Company and Dexcom Bring ŌURA Valuation to $5.2 Billion ŌURA , the company behind Oura ...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
It can be very overwhelming scrolling though job board after job board in search of a position that fits your wants and needs. Let us take t...
-
As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Pred...
No comments:
Post a Comment